A Hepatitis C Virus-Associated Decompensated Cirrhotic Patient Who Showed the Disappearance of Hepatic Encephalopathy, Ascites, and Pleural Effusion by Antiviral Therapy with Sofosbuvir/Velpatasvir

Oral direct-acting antivirals (DAAs) are the main therapy for hepatitis C virus (HCV)-associated liver disease in Japan. Moreover, many DAAs include an indication for compensated liver cirrhosis. However, patients with decompensated HCV-associated cirrhosis have hitherto not been indicated for thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Tarao, Kazuo, Nozaki, Akito, Komatsu, Hirokazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Single Case
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138198/
https://www.ncbi.nlm.nih.gov/pubmed/34054397
http://dx.doi.org/10.1159/000511749

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138198/
https://www.ncbi.nlm.nih.gov/pubmed/34054397
http://dx.doi.org/10.1159/000511749

Ejemplares similares